Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LR607 in Resectable Stage IIA-IIIB Non-small Cell Lung Cancer
NCT07534033Phase 2Recruiting
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of lactobacillus rhamnosus LR607 in non-small cell lung cancer (NSCLC), sponsored by Southern Medical University Zhujiang Hospital. Started Dec 2025; status: recruiting.
02
Drugs
lactobacillus rhamnosus LR607
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT07534033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07534033.